News

The CTA is Back, Back Again

By EsqSocial Corporation 24/12/24

The Corporate Transparency Act (“CTA”) and its reporting requirements are back in effect. The Fifth Circuit Court of Appeals has granted the U.S. Government’s motion for an emergency stay of the nationwide CTA injunction....

Fifth Circuit Stays Injunction Halting Corporate Transparency Act’s Enforcement; Treasury Updates Deadline to January 13, 2025 for Certain Companies

By EsqSocial Corporation 24/12/24

On December 23, 2024, the US Court of Appeals for the Fifth Circuit issued an order granting the government's emergency motion for a stay pending appeal of the preliminary injunction against the Corporate Transparency Act (CTA), which the US District Court for the Eastern District of Texas grante

Enough is (Apparently) Enough - Part I

By EsqSocial Corporation 24/12/24

The Buckeye Institute Files Amicus Brief in Newman v. Moore et al.

Feeble § 101 Litigation Position Results in Significant Award of Fees and Costs

By EsqSocial Corporation 24/12/24

The District Court of Delaware recently confirmed an award of $9.15 million in attorney’s fees and costs to defendant Elysium Health, Inc. (Elysium), resulting from what it determined to be insubstantial litigation positions taken by plaintiffs ChromaDex, Inc.

The Compliance Balancing Act: How Less Complexity Can Mean More ROI

By EsqSocial Corporation 24/12/24

What if less could mean more? For organizations grappling with the complexity of managing compliance across multiple vendors, systems, and workflows, this question is more than theoretical. It’s a strategic imperative....
By: NAVEX

Is your trademark in use? CIPO targets “deadwood” in 2025 and what you should expect

By EsqSocial Corporation 24/12/24

Beginning in January 2025, the Canadian Trademarks Office (CIPO) will start proactively and unilaterally (i.e., without a request by a third party) sending notices to registered trademark owners requiring them to prove that they recently used their trademarks in Canada, or risk losing their regis

Relevance of Trade Secret Ownership for Misappropriation: I-Mab Biopharma v. Inhibrx Inc.

By EsqSocial Corporation 24/12/24

In I-Mab Biopharma v. Inhibrx, Inc., a trade secret misappropriation case, a federal jury in Delaware sided with the defendants, Inhibrx and its co-founder Brendan Eckelman, on all counts.

Massachusetts Jury Sets New Record Under Federal Defend Trade Secrets Act With $452 Million Damages Award

By EsqSocial Corporation 24/12/24

In December, a Massachusetts corporation won the largest jury verdict ever awarded under the federal Defend Trade Secrets Act (DTSA). The award of $452 million is part of a recent trend of massive awards to trade secret owners....

Fifth Circuit Lifts Injunction on Corporate Transparency Act: BOI Filing Deadline Reinstated for January 1, 2025

By EsqSocial Corporation 24/12/24

UPDATE as of 12/24/24: FinCen has updated their website extending the beneficial ownership reporting deadline for reporting companies that were created or registered prior to January 1, 2024, from January 1, 2025, to January 13, 2025, for reporting companies formed after September......

Tax and Disclosure Considerations Related to Executive Security Benefits

By EsqSocial Corporation 24/12/24

Key Takeaways - Executives and companies may deduct the cost of security benefits that meet certain requirements under the Treasury Regulations Public companies are generally required to disclose the cost of security benefits they provide to their executive teams in certain filings with the Secu

Pages